Clinical Trial Update: A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of SHR-2173 in Patients With Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

Phase I clinical study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple subcutaneous injections of SHR-2173 in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• SHR-2173

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED